BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35858631)

  • 21. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in South Indian Women Using AES-2006 Criteria.
    Thathapudi S; Kodati V; Erukkambattu J; Katragadda A; Addepally U; Hasan Q
    Int J Endocrinol Metab; 2014 Jan; 12(1):e12470. PubMed ID: 24696694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
    Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
    Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S
    Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
    Cibula D; Hill M; Fanta M; Sindelka G; Zivny J
    Hum Reprod; 2001 May; 16(5):940-4. PubMed ID: 11331641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome.
    Koiou E; Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Panidis D
    Gynecol Endocrinol; 2013 Mar; 29(3):250-3. PubMed ID: 23216335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome.
    Hahn S; Bering van Halteren W; Roesler S; Schmidt M; Kimmig R; Tan S; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):175-81. PubMed ID: 16705549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome.
    Velazquez ME; Millan AL; Rojo M; Abruzzese GA; Cocucci SE; Iglesias Molli AE; Frechtel GD; Motta AB; Cerrone GE
    Front Endocrinol (Lausanne); 2021; 12():604215. PubMed ID: 34054718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycystic ovaries and associated clinical and biochemical features in young women.
    Michelmore KF; Balen AH; Dunger DB; Vessey MP
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):779-86. PubMed ID: 10619984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
    Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
    Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
    Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D
    Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
    Housman E; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
    Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R
    Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arterial stiffness measured by cardio-ankle vascular index is greater in non-obese young women with polycystic ovarian syndrome.
    Kilic D; Kilic ID; Sevgican CI; Kilic O; Alatas E; Arslan M; Avci E; Guler T
    J Obstet Gynaecol Res; 2021 Feb; 47(2):521-528. PubMed ID: 33145911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian morphology and endocrine function in polycystic ovary syndrome.
    Tena G; Moran C; Romero R; Moran S
    Arch Gynecol Obstet; 2011 Dec; 284(6):1443-8. PubMed ID: 21243502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
    Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
    Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.